Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Heterogeneity Mapping of Protein Expression in Tumors using Quantitative Immunofluorescence07:54

Heterogeneity Mapping of Protein Expression in Tumors using Quantitative Immunofluorescence

19.1K
Here we describe a method to quantify molecular heterogeneity in histological sections of tumor material using quantitative immunofluorescence, image analysis, and a statistical measure of heterogeneity. The method is intended for use in clinical biomarker development and...
19.1K
Classifying Matter by Composition03:35

Classifying Matter by Composition

89.5K
Matter: Pure Substances and Mixtures
According to its composition, the matter can be classified into two broad categories — pure substances and mixtures. 
A pure substance is a form of matter that has a constant composition throughout with uniform properties. For example, any sample of sucrose has the same composition and same physical properties, such as melting point, color, and sweetness, regardless of the source from which it is isolated. 
A mixture is composed of two or...
89.5K
Classifying Matter by State02:49

Classifying Matter by State

102.5K
Chemistry is the study of matter and the changes it undergoes. Matter is anything that has mass and occupies space. Matter is all around us; the air, water, soil, mountains, even our bodies are all examples of matter. Matter is divided into three states — solid, liquid, and gas — that are commonly found on earth. The fourth state of matter, plasma, occurs naturally in the interiors of stars. 
102.5K
Physical and Chemical Properties of Matter02:57

Physical and Chemical Properties of Matter

165.3K
The characteristics that enable us to distinguish one substance from another are called properties.
165.3K
The Atomic Theory of Matter02:59

The Atomic Theory of Matter

126.8K
The earliest recorded discussion of the basic structure of matter comes from ancient Greek philosophers. Leucippus and Democritus argued that all matter was composed of small, finite particles that they called atomos, meaning “indivisible.” Later, Aristotle and others came to the conclusion that matter consisted of various combinations of the four “elements” — fire, earth, air, and water — and could be infinitely divided. Interestingly, these philosophers...
126.8K
States of Matter01:20

States of Matter

2.7K
Solids, liquids, and gases are the three states of matter commonly found on Earth. A solid is rigid and possesses a definite shape. A liquid flows and takes the shape of its container, except it forms a flat or slightly curved upper surface when acted upon by gravity. Both liquid and solid samples have volumes nearly independent of pressure. A gas takes both the shape and volume of its container.
Scientists have discovered a fourth state of matter, plasma, that occurs naturally in the interiors...
2.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Biomarker analysis from patients with metastatic PDAC treated with TGFβ antibody, NIS793, plus abraxane+gemcitabine vs. abraxane+gemcitabine alone in a phase II, open label, randomized study.

Clinical cancer research : an official journal of the American Association for Cancer Research·2026
Same author

Flourine-18 Prostate-Specific Membrane Antigen-1007 Positron Emission Tomography Imaging in Staging of Primary and Secondary Prostate Cancer-A Retrospective Observational Cohort Study.

JU open plus·2026
Same author

Nivolumab and Ipilimumab for Metastatic Castration-Resistant Prostate Cancer With an Immunogenic Signature: The Multicenter, Two-Cohort, Phase II NEPTUNES Study.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2025
Same author

Defining the genetic determinants of CD8<sup>+</sup> T cell receptor repertoire in the context of immune checkpoint blockade.

Science advances·2025
Same author

Distinct immune cell infiltration patterns in pancreatic ductal adenocarcinoma (PDAC) exhibit divergent immune cell selection and immunosuppressive mechanisms.

Nature communications·2025
Same author

Tumour purity assessment with deep learning in colorectal cancer and impact on molecular analysis.

The Journal of pathology·2024
Same journal

Predictive biomarkers of response in metastatic prostate cancer: paving the way for a new era of precision medicine.

Expert review of anticancer therapy·2026
Same journal

Barriers to the use of brachytherapy for treatment of cervical cancer and prostate cancer in low- and middle-income countries.

Expert review of anticancer therapy·2026
Same journal

The dual role of Schlafen11 in brain tumors: Jekyll and Hyde.

Expert review of anticancer therapy·2026
Same journal

Central nervous system-related permanent consequences in long-term survivors of pediatric Langerhans cell histiocytosis: a clinical overview and monitoring strategies.

Expert review of anticancer therapy·2026
Same journal

RTsDEN: reverse task attention enabled deep learning model for lung cancer detection using computed tomography.

Expert review of anticancer therapy·2026
Same journal

The potential impact of glucagon-like peptide 1 receptor agonists for the treatment of endometrial carcinoma.

Expert review of anticancer therapy·2026
See all related articles

Related Experiment Video

Updated: Jan 19, 2026

Heterogeneity Mapping of Protein Expression in Tumors using Quantitative Immunofluorescence
07:54

Heterogeneity Mapping of Protein Expression in Tumors using Quantitative Immunofluorescence

Published on: October 25, 2011

19.1K

Tumor heterogeneity: does it matter?

Casmir Turnquist1, Robert A Watson2, Andrew Protheroe2

  • 1University of Oxford Medical School, John Radcliffe Hospital , Oxford , UK.

Expert Review of Anticancer Therapy
|September 13, 2019
PubMed
Summary
This summary is machine-generated.

Tumor heterogeneity, the diversity of cancer cells, is increasingly detected but its clinical impact on prognostication and treatment remains unclear. New technologies may soon reveal its significance.

Keywords:
Cancer stem celldrug resistanceliquid biopsytumor evolutiontumor heterogeneity

More Related Videos

Classifying Matter by Composition
03:35

Classifying Matter by Composition

89.5K
Classifying Matter by State
02:49

Classifying Matter by State

102.5K

Related Experiment Videos

Last Updated: Jan 19, 2026

Heterogeneity Mapping of Protein Expression in Tumors using Quantitative Immunofluorescence
07:54

Heterogeneity Mapping of Protein Expression in Tumors using Quantitative Immunofluorescence

Published on: October 25, 2011

19.1K
Classifying Matter by Composition
03:35

Classifying Matter by Composition

89.5K
Classifying Matter by State
02:49

Classifying Matter by State

102.5K

Area of Science:

  • Oncology
  • Genomics
  • Cancer Biology

Background:

  • Tumors exhibit cellular diversity (heterogeneity) at genetic, epigenetic, and phenotypic levels.
  • Advanced sequencing technologies reveal greater complexity in cancer genotypes and phenotypes.
  • Despite detection advancements, the clinical significance of tumor heterogeneity is still debated.

Purpose of the Study:

  • To review evidence on the importance of tumor heterogeneity in cancer prognostication.
  • To evaluate the role of tumor heterogeneity in the development of targeted therapies and treatment resistance.
  • To summarize current understanding and assess emerging clinical developments.

Main Methods:

  • Review of existing literature on tumor heterogeneity detection methods (e.g., in situ hybridization, sequencing).
  • Analysis of evidence supporting or refuting the clinical impact of heterogeneity.
  • Evaluation of ongoing experimental and clinical research.

Main Results:

  • Tumor heterogeneity is widely observed across various cancers using multiple detection methods.
  • The direct clinical impact of heterogeneity on patient outcomes and treatment efficacy is not yet fully established.
  • Theoretical understanding and in vitro findings have yet to translate into significant clinical benefits.

Conclusions:

  • While tumor heterogeneity is a complex biological feature, its direct clinical utility remains limited.
  • Technological innovations and ongoing clinical trials hold promise for future clinical translation.
  • Further research is needed to bridge the gap between detecting heterogeneity and achieving meaningful clinical benefits in cancer care.